Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN005245 | 481.3174 | 3.58 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 509.4808 | 7.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 523.3648 | 3.46 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 523.4965 | 8.08 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 537.5127 | 9.09 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 545.3465 | 3.46 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 549.3802 | 3.58 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 565.5429 | 11.45 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 571.362 | 3.59 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 616.507 | 11.51 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 618.5231 | 11.7 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 619.5889 | 11.99 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 620.5395 | 11.99 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 621.474 | 5.18 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 621.6067 | 12.27 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 635.4884 | 5.6 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 635.6232 | 12.42 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 645.6091 | 12.06 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 649.467 | 5.07 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 650.5968 | 15.64 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 663.4839 | 7.6 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 663.6503 | 12.68 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 666.5242 | 11.39 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 668.5385 | 11.65 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 668.5394 | 11.79 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 670.5544 | 11.92 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 673.6411 | 12.3 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 675.4857 | 5.23 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 676.5511 | 6.41 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 677.6717 | 12.91 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 689.5003 | 7.87 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 705.5304 | 8.07 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 705.5308 | 7.06 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 717.5316 | 9.94 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 717.5323 | 7.25 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 719.5467 | 7.83 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 730.5966 | 9.16 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 733.5635 | 9.16 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 743.5472 | 10.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 743.5482 | 10.2 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 746.5104 | 6.35 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 747.5764 | 9.71 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 753.5307 | 9.03 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 756.6112 | 9.45 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 757.5634 | 7.74 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 759.5058 | 6.26 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 759.5795 | 9.45 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 763.5129 | 8.58 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 763.517 | 7.77 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 765.5287 | 7 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 767.5462 | 9.66 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 769.5623 | 7.39 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 769.5624 | 7.39 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 773.5946 | 12.01 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 774.6733 | 13.28 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 777.5315 | 5.83 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 777.532 | 7.2 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 781.5626 | 7.36 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 781.5634 | 7.77 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 783.5783 | 9.11 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 787.537 | 7.43 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 788.6776 | 12.07 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 791.5462 | 11.31 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 793.562 | 7.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 793.5649 | 7.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 797.5924 | 9.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 802.7053 | 13.67 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 809.5939 | 9.22 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 812.6788 | 11.95 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 819.5777 | 7.43 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 827.6455 | 12.25 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 831.5747 | 9.22 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 831.579 | 7.63 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 831.5793 | 7.38 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 831.583 | 7.22 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 835.6087 | 9.44 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 837.5505 | 7.81 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 837.6275 | 11.95 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 838.6922 | 11.99 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 839.5668 | 8.99 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 843.5797 | 11.76 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 846.766 | 15 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 851.6404 | 11.66 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 852.7181 | 13.44 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 854.7372 | 13.99 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 855.5767 | 7.21 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 855.5806 | 7 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 857.5898 | 7.73 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 859.6088 | 9.53 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 859.6132 | 8.95 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 870.7686 | 14.39 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 871.6313 | 11.93 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 872.7843 | 14.97 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 873.7209 | 12.75 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 883.6149 | 8.68 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 888.8125 | 16.14 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 912.8162 | 15.28 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 928.7518 | 13.42 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 1346.9245 | 12.47 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 1402.9868 | 12.88 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 1405.0023 | 13.13 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005245 | 1455.016 | 12.9 | Minutes | ST003196 | POSITIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells |
